Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 17, 10:01
Statera BioPharma Cash from Financing (TTM): -1.597M for Sept. 30, 2022
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | -1.597M |
| June 30, 2022 | -1.637M |
| Date | Value |
|---|---|
| March 31, 2022 | 15.93M |
| December 31, 2021 | 20.99M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.637M
Minimum
Jun 2022
20.99M
Maximum
Dec 2021
8.422M
Average
7.169M
Median
Cash from Financing (TTM) Benchmarks
| Humanigen Inc | -1.537M |
| Cannabis Global Inc | 0.6212M |
| Item 9 Labs Corp | 2.321M |
| Cantabio Pharmaceuticals Inc | 1.055M |
| Affymax Inc | -- |